+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Prevalence of metabolic syndrome in Iranian patients with schizophrenia: A systematic review and meta-analysis



Prevalence of metabolic syndrome in Iranian patients with schizophrenia: A systematic review and meta-analysis



Diabetes & Metabolic Syndrome 13(1): 143-147



Metabolic syndrome as a set of cardiovascular risk factors is highly prevalent among patients with schizophrenia. It can also lead to cardiovascular diseases and shorten lifespan. This systematic review and meta-analysis aimed to estimate the prevalence of metabolic syndrome among Iranian patients with schizophrenia. Five national studies were retrived without any time limitation and reported in the present systematic review and meta-analysis. Data bases including Web of Science, Google Scholar, PubMed and Scopus were used to search and retrieve related articles. Keywords including "schizophrenia", "metabolic syndrome", "MetSyn" and "X syndrome", and their combinations were used. Data were analyzed using the meta-analysis method and the random effects model. The heterogeneity of the studies was evaluated using the I2 index and data was analyzed using the STATA software version 12. The analysis of five selected articles with a sample size of 1589 people showed that the prevalence of metabolic syndrome in patients with schizophrenia was reported as 23.9% (95% CI: 14.8-33). The prevalence of metabolic syndrome in women and men was reported as 34% (95% C: 19-49) and 10.8% (95% CI: 2.9-18.7), respectively. According to the meta-regression analysis, no correlation was reported between the prevalence of metabolic syndrome and the mean age of patients (p = 0.607), year of publication of articles (p = 0.350), sample size (p = 0.392) and duration of disease (p = 0.607). Also, about one fourth of the patients with schizophrenia were suffering from metabolic syndrome. The identification of at-risk patients is necessary to control and treat metabolic syndrome.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 066088439

Download citation: RISBibTeXText

PMID: 30641687

DOI: 10.1016/j.dsx.2018.08.014


Related references

Prevalence and determinants of metabolic syndrome in patients with schizophrenia: A systematic review and meta-analysis of Indian studies. Asian Journal of Psychiatry 22: 86-92, 2017

Prevalence of Metabolic Syndrome among Iranian Population: A Systematic Review and Meta-analysis. Iranian Journal of Public Health 46(4): 456-467, 2017

Prevalence of Metabolic Syndrome and Its Components in the Iranian Adult Population: A Systematic Review and Meta-Analysis. Iranian Red Crescent Medical Journal 17(12): E24723, 2016

Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders--a systematic review and meta-analysis. Schizophrenia Bulletin 39(2): 306-318, 2013

Metabolic syndrome prevalence in the Iranian adult's general population and its trend: A systematic review and meta-analysis of observational studies. Diabetes and Metabolic Syndrome 12(3): 441-453, 2018

Prevalence of poststroke depression in Iranian patients: a systematic review and meta-analysis. Neuropsychiatric Disease and Treatment 14: 3073-3080, 2018

Prevalence of hepatitis C virus genotypes in Iranian patients: a systematic review and meta-analysis. Hepatitis Monthly 14(12): E22915, 2015

Prevalence of depression among Iranian patients with rheumatoid arthritis: a systematic review and meta-analysis. Open Access Rheumatology 11: 53-59, 2019

Prevalence of hepatitis C infection in Iranian hemodialysis patients: An updated systematic review and meta-analysis. Journal of Research in Medical Sciences 22: 123, 2017

Prevalence of Metabolic Syndrome in Mexico: A Systematic Review and Meta-Analysis. Metabolic Syndrome and Related Disorders 16(8): 395-405, 2018

The Prevalence of Metabolic Syndrome in Iran: A Systematic Review and Meta-analysis. Iranian Journal of Public Health 47(4): 473-480, 2018

The relationship between cognitive impairment in schizophrenia and metabolic syndrome: a systematic review and meta-analysis. Psychological Medicine 47(6): 1030-1040, 2016

Data on prevalence of metabolic syndrome in Turkey: Systematic review, meta-analysis and meta-regression of epidemiological studies on cardiovascular risk factors. Turk Kardiyoloji Dernegi Arsivi 46(7): 591-601, 2018

Prevalence of metabolic syndrome in Bangladesh: a systematic review and meta-analysis of the studies. Bmc Public Health 18(1): 308, 2018

The Prevalence of Metabolic Syndrome in Alcohol Use Disorders: A Systematic Review and Meta-analysis. Alcohol and Alcoholism 51(5): 515-521, 2017